Search Within

Mark Kris

  1. "Advanced Practice Providers"
Formats
  1. Meeting Abstract (16)
  2. Journal Article (10)
Groups
  1. Advanced Practice Providers (26)
  2. Department of Medicine (26)
  3. Solid Tumor Oncology Division (26)
  4. Thoracic Oncology (26)
  5. Nursing (20)
  6. Radiology, Department of (16)

More Groups

People
  1. Christopher Azzoli (15)
  2. Lee Krug (15)
  3. Michelle Ginsberg (14)
  4. Vincent Miller (13)
  5. Megan Dunne (12)
  6. Leslie Tyson (11)

More People

Years
  1. 2023 (1)
  2. 2019 (2)
  3. 2018 (3)
  4. 2014 (1)
  5. 2013 (2)
  6. 2012 (2)

More Years

Publications
  1. Journal of Clinical Oncology (8)
  2. Journal of Thoracic Oncology (5)
  3. Clinical Cancer Research (3)
  4. Cancer (2)
  5. Lung Cancer (2)
  6. Molecular Cancer Therapeutics (2)

More Publications

Publishers
  1. American Society of Clinical Oncology (8)
  2. American Association for Cancer Research (6)
  3. Elsevier Inc. (5)
  4. Elsevier Ireland Ltd. (2)
  5. Wiley Blackwell (2)
  6. Cold Spring Harbor Laboratory Press (1)

More Publishers

Results (26)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Phase II study of cabozantinib in patients with MET-altered lung cancers
    Meeting Abstract

    Harada, G.; Santini, F. C.; Repetti, R. W.; Chang, J.; Yang, S. R.; Lin, Y. T.; Moses, K. A.; Falcon, C.; Wilhelm, C. J.; Goldstein, M.; more...
    Annals of Oncology (2023)

    Fulltext@MSK | Save
  • 89Zr-trastuzumab PET/CT for prediction of response to HER2-targeted therapy in patients with HER2 mutant lung cancer: An exploratory phase 2 trial
    Meeting Abstract

    Ulaner, G.; Offin, M.; Scaltriti, M.; Myers, M.; Venkatesh, A.; Panora, E.; Kris, M.; Rudin, C.; Arcila, M.; Lyashchenko, S.; more...
    Journal of Nuclear Medicine (2019)

    Fulltext@MSK | Save
  • Exceptional responders with invasive mucinous adenocarcinomas: A phase 2 trial of bortezomib in patients with KRAS G12D-mutant lung cancers
    Journal Article

    Drilon, A.; Schoenfeld, A. J.; Arbour, K. C.; Litvak, A.; Ni, A.; Montecalvo, J.; Yu, H. A.; Panora, E.; Ahn, L.; Kennedy, M.; more...
    Cold Spring Harbor Molecular Case Studies (2019)

    Fulltext@MSK | Save
  • A multi-histology basket trial of ado-trastuzumab emtansine in patients with HER2 amplified cancers
    Meeting Abstract

    Li, B. T.; Makker, V.; Buonocore, D. J.; Offin, M. D.; Olah, Z. T.; Panora, E.; Shen, R.; Ho, A. L.; Yaeger, R.; Iyer, G.; more...
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • Molecular and imaging predictors of response to ado-trastuzumab emtansine in patients with HER2 mutant lung cancers: An exploratory phase 2 trial
    Meeting Abstract

    Li, B.; Offin, M.; Hembrough, T.; Cecchi, F.; Shen, R.; Olah, Z.; Panora, E.; Myers, M.; Brzostowski, E.; Buonocore, D.; more...
    Journal of Thoracic Oncology (2018)

    Fulltext@MSK | Save
  • Safety and efficacy of re-treating with immunotherapy after immune-related adverse events in patients with NSCLC
    Journal Article

    Santini, F. C.; Rizvi, H.; Plodkowski, A. J.; Ni, A.; Lacouture, M. E.; Gambarin-Gelwan, M.; Wilkins, O.; Panora, E.; Halpenny, D. F.; Long, N. M.; more...
    Cancer Immunology Research (2018)

    Fulltext@MSK | Save
  • Trial of a 5-day dosing regimen of temozolomide in patients with relapsed small cell lung cancers with assessment of methylguanine-DNA methyltransferase
    Journal Article

    Zauderer, M. G.; Drilon, A.; Kadota, K.; Huberman, K.; Sima, C. S.; Bergagnini, I.; Sumner, D. K.; Travis, W. D.; Heguy, A.; Ginsberg, M. S.; more...
    Lung Cancer (2014)

    Fulltext@MSK | Save
  • A phase II trial of paclitaxel, pemetrexed and bevacizumab in patients with untreated, advanced lung cancers
    Meeting Abstract

    Pietanza, M. C.; Hellmann, M. D.; Rizvi, N.; Azzoli, C. G.; Smith-Marrone, S.; Fiore, J.; Tyson, L. B.; Sumner, D. K.; Hergianto, A. B.; Kass, S. L.; more...
    Journal of Thoracic Oncology (2013)

    Fulltext@MSK | Save
  • Harnessing technology to improve clinical trials: study of real-time informatics to collect data, toxicities, image response assessments, and patient-reported outcomes in a phase II clinical trial
    Journal Article

    Pietanza, M. C.; Basch, E. M.; Lash, A.; Schwartz, L. H.; Ginsberg, M. S.; Zhao, B.; Shouery, M.; Shaw, M.; Rogak, L. J.; Wilson, M.; more...
    Journal of Clinical Oncology (2013)

    Fulltext@MSK | Save
  • 5-day dosing schedule of temozolomide in relapsed sensitive or refractory small cell lung cancer (SCLC) and methyl-guanine-DNA methyltransferase (MGMT) analysis in a phase II trial
    Meeting Abstract

    Drilon, A. E. D. C.; Kyuichi, K.; Huberman, K. H.; Sima, C. S.; Fiore, J. J.; Yu, H. A.; Varghese, A. M.; Sumner, D. K.; Travis, W. D.; Heguy, A.; more...
    Journal of Clinical Oncology (2012)

    Fulltext@MSK | Save